About Steven Pusterla
Steven possesses a rare ability to see big-picture opportunities with clarity while applying a disciplined, analytical approach to develop actionable implementation plans. His unique skill set consistently drives success across both large corporate environments and early-stage startups, where he has built, scaled, and transformed organizations for sustainable growth. By operating with thorough preparation and precision, Steven optimizes outcomes, minimizes risk, and delivers visionary strategies with seamless execution. His leadership philosophy—anchored in accountability, innovation, and a people-first culture—fosters high-performing teams and lasting organizational success.
As a Chief Executive Officer and senior commercial leader, Steven brings a proven track record in global market expansion, operational excellence, strategic partnerships, and customer-centric innovation. He has guided organizations through FDA approval pathways, manufacturing scale-up, supply chain optimization, and value-based care transitions, consistently improving efficiency, reducing costs, and driving growth. His mission is to redefine industry standards, accelerate impact, and create a more efficient, accessible, and transformative future for healthcare worldwide.
Professional Experience
PRINCIPAL CONSULTANT * CEO * Healthcare ENTRPRENEUR
2021 - Present
At Steep Health, I lead client success by managing strategic engagements and providing high-level consultation across all business functions. A seasoned executive with a proven record of driving sustained growth and profitability, I bring deep expertise in global go-to-market strategy, health economic value creation, and transformational business growth. Adept at identifying high-value opportunities, creating new markets, and driving wide-scale adoption, I have extensive experience leading global product launches that accelerate entry into emerging markets while ensuring operational excellence and regulatory alignment.
My leadership spans the full scope of CEO responsibilities—corporate formation, P&L management, regulatory approval strategies, and manufacturing scale-up—while also delivering commercial execution, portfolio expansion, and operational guidance. I am skilled in optimizing supply chains, sourcing talent, partners, and raw materials, and applying Lean Six Sigma practices to improve efficiency, reduce waste, and lower Cost of Goods Sold (COGS). These capabilities, combined with a strong background in business and financial leadership, enable me to guide MedTech and healthcare organizations through scale-up, commercialization, and sustained growth.
At Steep Health, I collaborate with MedTech companies, health systems, and health plans to launch and expand innovative programs, solutions, and technologies. My work includes devising market entry and expansion strategies, developing sales tools and ROI models, and providing insights into customer demographics and business needs. I also strengthen internal and external communications, foster stakeholder and board alignment, and drive execution that consistently exceeds revenue targets.
Previously serving as Chief Growth Officer, Chief Marketing Officer, and Vice President of Strategic Sales, I bring a broad, cross-functional perspective to CEO leadership. Our success is demonstrated by partners achieving more than 50% revenue growth, securing new business contracts exceeding $250K, and establishing recurring revenue streams above $30K per month—clear evidence of the ability to combine strategic vision, operational excellence, and commercial execution to deliver measurable, lasting results.
Chief commercial officer
2025 - Present
As Commercial Advisor to Syntactiq, I support U.S. and global market strategy, business development, and strategic partnership growth across diabetes technology, life sciences, academic research, and healthcare data sectors. My focus is on forging long-term collaborations that accelerate adoption of Syntactiq’s AI-powered analytics platform—enabling faster, more efficient, and fiscally responsible ways to analyze, interpret, and apply real-world diabetes data. In addition, I help guide portfolio expansion and new offerings, ensuring that Syntactiq’s solutions evolve with market needs and deliver measurable value. By connecting healthcare organizations, device manufacturers, and research institutions with advanced AI-driven capabilities, I provide both commercial insight and operational guidance to position Syntactiq as a trusted partner in driving evidence-based decision-making and unlocking sustainable growth.
Syntactiq responsibly drives innovation in diabetes care by transforming patient data into actionable insights through its proprietary AI platform. With an emphasis on ethical data collection, regulatory alignment, and scientific rigor, the company empowers researchers, clinicians, and industry partners to advance diabetes research and clinical development with greater speed and accuracy. Through ongoing portfolio enhancements and expansion into adjacent offerings, Syntactiq is building a comprehensive ecosystem of solutions that support product innovation, trial optimization, and healthcare delivery. In partnership with forward-thinking organizations, we are unlocking new opportunities to accelerate product development, improve clinical outcomes, and optimize care delivery through meaningful, data-driven intelligence. Together, we are shaping a future where real-world evidence seamlessly informs both research and care—advancing the global mission of better diabetes management and improved quality of life.
Chief commercial officer
2024 - 2025
At OneTwo Analytics, I spearheaded the design, execution, and management of all commercial affairs for this pioneering early-stage organization. Leveraging my passion for enhancing diabetes care, combined with deep expertise in the field and extensive relationships with key manufacturers and clinical entities, I successfully secured pivotal contracts and pilot programs with new U.S.-based organizations.
As Chief Commercial Officer, I conducted comprehensive global market analysis within the diabetes OEM, provider, and insurer sectors, orchestrated global expansion plans, and directed U.S. launch strategies.
My role was instrumental in fostering investor relations to support fundraising and strategic growth initiatives. Notable achievements include leading all planning, alliance management, and regulatory approval processes, which culminated in numerous new Diabetes Technology Stack development contracts, the initiation of clinical pilots, and securing Class 1 exempt status for our entire portfolio of solutions with the FDA. I also managed P&L, created U.S. contract structures, formed a U.S.-based C-Corp, and facilitated critical business functions such as banking, insurance, accounting, and invoicing for the U.S. corporation.
Additionally, I formulated partnership strategies with nonprofit diabetes organizations and device manufacturers specializing in CGM and Insulin Delivery, enhancing awareness and driving business growth. I spearheaded initiatives for new market entry and expansion, crafted branding plans, and developed health economic value framework, while also facilitating reimbursement and Return on Investment models for our clinical partners.
My expertise further extended to organizing comprehensive internal and external communication plans, developing demographic profiles for the organization, and creating forecasting tools. Moreover, I led the creation and execution of integrated marketing, social media, and business development strategies, which notably resulted in securing over $2M contracts in Q3 2024.
Director Strategic Accounts * Cardiac & Vascular Group Director Strategic Partnerships * DIABETES
2015 - 2021
As the Director of Strategic Accounts, I played a pivotal role in orchestrating the development of a five-year Cardiac and Vascular Group Executive Partnership, successfully securing a multi-year consulting agreement. In 2020, I achieved Top Rank status among 35 United States regions. My accomplishments include the execution of a capitated contract structure for the Aortic business, resulting in a multi-year contract extension valued at $2 million for the Transcatheter Aortic Valve Replacement (TAVR) business. I also implemented a performance guarantee Heart Value contract, securing a minimum annual conversion of previously unpenetrated business, amounting to $1 million.
Through strategic contracting and conversion strategies, I generated over $7 million in new revenue, significantly increasing market share in associated product categories. In overseeing consistent growth and fostering executive-level relationships, I implemented crucial business strategies within Western integrated delivery networks, surpassing annual revenues of $100 million.
Additionally, in my role as Director of Strategic Partnerships, I achieved noteworthy results, generating $1.2 million in revenue through the execution of bulk contracts, program structures, and marketing plans for government facilities. Pioneering diabetes strategies and value-based initiatives at Medtronic CEO's Signature Accounts, I secured over $3.6 million in annual recurring revenue. My responsibilities included executing $1 million in value-based technology partnerships and establishing a Pan-Medtronic Diabetes Surgical Readiness Program, focusing on high-demand populations. Leading a value-focused healthcare approach, I initiated unique strategies that drove disruption and established competitive barriers in the diabetes market. As the Diabetes Liaison for Medtronic CEO's Valued-Based Healthcare Transformation Initiative, I introduced provider and patient marketing, public relations campaigns, and advertising, resulting in increased demand for new solutions. Lastly, I cultivated solid C-suite relationships, presenting new value-based contracts, custom implementation plans, and value propositions to risk-bearing health system and health plan executives
Strategic Account Manager
2013 - 2015
With this organization, I spearheaded contracting and conversion strategies for multiple United States strategic accounts, leading complex laparoscopic and robotic Thoracic procedures for a start-up, which resulted in robust YoY revenue growth. I cultivated sales tactics, IDN contracts, strategies, value propositions, and custom implementation plans with Strategic Accounts for newly acquired thoracic biosurgical technology, resulting in consistent revenue growth and development of emerging markets.
Regional, Market Development, Marketing, Professional Education & Training Manager, Sales Representative * Ethicon Endo Surgey * Ethicon * J&J MEDICAL
1999 - 2013
When working at Johnson & Johnson, I was recognized with a 1st ranking out of 23 Market Development Managers, achieving $7.4M with a $1.1M increase. I accelerated revenue from $27k to over $2.4M in five years, generating significant growth in the Northeast Region. I instituted innovative marketing programs and educational pathways across the U.S., the U.K., Japan, and China. Recruited, trained, and performance managed numerous individuals and teams throughout the Northeast. I surpassed revenue goals and business plans, while maintaining award-winning productivity. Furthermore, I created several marketing, professional education, and public relations campaigns that showcased unique patient and provider benefit statements. Areas of focus included Bariatric, Cardiovascular, Diabetes, Epidemiology, Infection Prevention, Gynecology, Orthopedic, Plastic, and Surgical Oncology markets.
Approach
Core Strengths
Vision of Success
Core Strengths
- Strategic Vision & Market Expansion
- Operational & Manufacturing Excellence
- Healthcare Ecosystem Leadership
- Commercial & Growth Acceleration
- Executive Relationship Building
- People-First Leadership & Innovation
Leadership Goals
Vision of Success
Core Strengths
As Chief Executive Officer, my priority is to establish the organization as a market leader by expanding market share, accelerating financial growth, and delivering measurable results. I will leverage proven strategies, innovative solutions, and value-based approaches to strengthen brand presence and build transformative partnerships. By
As Chief Executive Officer, my priority is to establish the organization as a market leader by expanding market share, accelerating financial growth, and delivering measurable results. I will leverage proven strategies, innovative solutions, and value-based approaches to strengthen brand presence and build transformative partnerships. By empowering high-performing teams and ensuring operational excellence, I will create sustainable growth while laying the foundation for a successful strategic acquisition or Initial Public Offering (IPO) that maximizes stakeholder and investor value.
Vision of Success
Vision of Success
Vision of Success
Driven by a bold vision to reshape healthcare, I aim to position organizations as global leaders through transformative strategies, operational excellence, and a people-first culture that fuels innovation and growth. By forging meaningful partnerships and delivering measurable outcomes, I empower organizations not only to adapt but to lea
Driven by a bold vision to reshape healthcare, I aim to position organizations as global leaders through transformative strategies, operational excellence, and a people-first culture that fuels innovation and growth. By forging meaningful partnerships and delivering measurable outcomes, I empower organizations not only to adapt but to lead—redefining industry standards, accelerating impact, and shaping a more efficient, accessible, and groundbreaking future for healthcare worldwide.
Philanthropy